HCA Healthcare Inc.

HCA
Financial Analysis · Updated May 12, 2026 · Coverage 2026-Q2
Latest Q Revenue
$19.1B
Q1 2026 · +4.5% YoY
TTM ROIC
18.1%
FY2025 · NOPAT / Invested Capital (NOPAT = Operating Income × (1 − 25%); Invested Capital = Total Assets − Cash − Non-interest-bearing current liabilities) · WACC ~6.8% · Moat spread +11.2pp
Margin Profile
Gross 41.5%
Operating 15.8%
FCF 10.2%
FY2025
Net Debt
$48.8B
Cash $1.0B · Debt $49.8B · Q1 2026
Diluted Shares
227M
Q1 2026 · -9% (buyback)

Business Overview


ticker: HCA step: 01 generated: 2026-05-12 source: quick-research

HCA Healthcare, Inc. (HCA) — Business Overview

Business Description

HCA Healthcare is the largest for-profit healthcare provider in the United States — operates 190 hospitals + ~2,500 ambulatory sites of care (surgery centers, freestanding ERs, urgent care, physician clinics) in 19 states + United Kingdom. Captures ~5% of total US hospital admissions. Hub-and-spoke operating model links acute-care hospitals with outpatient centers to capture patients across the entire care continuum.

Revenue Model

~$75.6B FY2025 revenue from hospital-based services + outpatient services (now 42% of patient revenue). Payer mix FY2025: Managed Care + Private Insurance ~48%, Medicare ~32%, Medicaid ~10%, Self-Pay + International ~10%. Revenue per admission rises with patient acuity (case mix). Scale + payer-negotiation leverage = best-in-class economics among hospital systems.

Products & Services

  • 190 Acute Care Hospitals — Cardiac, oncology, neurosciences, orthopedic, emergency, women's services
  • ~125 Freestanding Outpatient Surgery Centers — Lower-cost surgical settings
  • Freestanding ERs + Urgent Care Centers — Capture entry-point patient acquisition
  • Physician Clinics — Primary + specialist physician network
  • Sarah Cannon Cancer Network — Multi-state oncology platform
  • HealthONE — Major Denver-area health system
  • MD Now Urgent Care — Florida urgent care platform
  • HCA International — UK operations (London Bridge Hospital, etc.)

Customer Base & Go-to-Market

~38M patient encounters annually. Concentrated in growth markets: Texas, Florida (largest), Tennessee, Virginia, Nevada, Colorado, Indiana. Geographic concentration in high-growth Sun Belt states + UK. Diversified payer mix protects from single-payer concentration risk.

Competitive Position

#1 US for-profit hospital operator by revenue + size. Competes with Tenet Healthcare (THC), Universal Health Services (UHS), Community Health Systems (CYH), HCA Florida vs nonprofits AdventHealth, Baptist, Memorial. Differentiation: scale + hub-and-spoke + data analytics + capital investment in growth corridors + acuity mix shift.

Key Facts

  • Founded: 1968
  • Headquarters: Nashville, TN
  • Employees: ~280,000 (caregivers + physicians + staff)
  • Exchange: NYSE (HCA)
  • Sector / Industry: Healthcare / Healthcare Facilities (Hospitals)
  • Market Cap: ~$110-120B
  • CEO: Sam Hazen (since 2019)

Financial Snapshot


ticker: HCA step: 04 generated: 2026-05-12 source: quick-research

HCA Healthcare, Inc. (HCA) — Financial Snapshot

Income Statement Summary

Metric FY2022 FY2023 FY2024 FY2025 YoY (25)
Revenue $60.2B $64.97B $70.6B $75.6B +7.1%
Same-Facility Admissions Growth -2.0% +3.6% +5.5% +2.4%
Adj EBITDA $12.2B $12.65B $13.88B $15.57B +12.1%
EBITDA Margin 20.3% 19.5% 19.7% 20.6% +90bps
Net Income $5.64B $5.24B $5.76B $6.78B +18%
Diluted EPS $19.20 $19.65 $22.00 $28.33 +29%

FY25: Same-facility admissions +2.4% in Q4; full-year inpatient + outpatient surgery + ER visits all positive. Adj EBITDA +12%; EBITDA margin 20.6% (record high). EPS +29% (driven by share buybacks compounding effect).

Cash Flow & Balance Sheet (FY2024)

Metric Value
Operating Cash Flow ~$11.5B
Free Cash Flow ~$6.5B
Capex ~$5.2B (record investment)
Cash & Equivalents ~$1.0B
Total Debt ~$42B
Net Debt/EBITDA ~2.7x
Buybacks $10B authorized (early 2026)

Key Ratios (approximate)

  • P/E: ~16x | EV/EBITDA: ~9-10x | FCF Yield: ~5.5%
  • Revenue Growth (TTM): ~7% | Op Margin: ~15%
  • Dividend Yield: ~1.0% | Modest dividend; capital return primarily via buybacks
  • Aggressive buybacks: ~$8-10B annually = ~7-8% share count reduction

Growth Profile

Long-term: 5-7% revenue growth (admissions + price/acuity) + 100bps margin expansion + 10-12% adj EBITDA growth + 12-15% EPS growth (with aggressive buybacks). $5.2B capex plan adds 600-700 beds annually + ORs + ASCs. Hub-and-spoke + AI/analytics = $400M resiliency program savings.

Forward Estimates

  • FY 2026: Revenue ~$80B; adj EBITDA $16-17B; adj EPS $29.10-31.50 (raised guidance)
  • ACA + Medicaid headwind: $600-900M EBITDA hit (manageable)
  • FY 2027: Adj EPS ~$33-36 with full-year 2026 buybacks compounding
  • $10B buyback authorization (Jan 2026) for 2026-27 execution

Deeper Financial Analysis

The fundamental tier adds 9 additional research dimensions for $HCA.

Revenue Breakdown
Segment revenue, geographic mix, product-line contribution margins, and cohort dynamics.
Financial Trends
Quarter-over-quarter momentum, leading indicators, and inflection point analysis.
Balance Sheet
Debt structure, liquidity runway, dilution risk, and working capital dynamics.
Capital Allocation
Buyback cadence, M&A appetite, dividend policy, and reinvestment priorities.
Returns on Capital (ROIC)
Multi-year ROIC vs. WACC, marginal returns on reinvestment, sales-to-invested-capital efficiency, and moat spread.
GET /api/v1/research/HCA/fundamental$1.00 · Bearer token required
Markdown: /stocks/hca/financials/md · → thesis · → memo